HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Migraine Supplement Firm Offers App To Keep Health Care 'Partners' Connected For Supplies

Executive Summary

NeuroHydrate shut down all meetings with health care “partners” to promote HM-Formula due to COVID-19. But with NeuroConnect smartphone app, it almost doubled product sample distribution.

You may also be interested in...



For Consumer Health Industry, Pandemic-Driven Buying Reveals Signs For Sustaining Sales Growth

"It's a great industry to be in with it being pandemic proof," says Natural Marketing Institute managing partner Steve French. "Consumers really want one-stop shopping in this situation. They want stores they can get into and get out of it," says IRI health care executive Kristin Hornberger.

Ordering Starts For Free OTC COVID-19 Tests; USPS Deliveries Expected Within Two Weeks

US consumers can order up to four rapid antigen tests per household through USPS website, or a phone hotline coming soon. Biden administration, which is working to buy another 500m tests soon, notes more OTC tests are becoming available through an accelerated pathway to support FDA reviews of for emergency use authorizations of tests with potential for large-scale manufacturing.

Record Number Of Mergers Forces US Regulatory Agencies’ Hand On Updating Enforcement Guides

Chairwoman Lina Khan says concerns about impact on consumer product markets from mergers prompted FTC, working with DoJ, to seek public input on modernizing federal merger guidelines to better detect and prevent illegal, anticompetitive deals in current markets.

Topics

UsernamePublicRestriction

Register

RS150689

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel